(VIANEWS) – Shares of Sorrento Therapeutics (NASDAQ Composite: SRNE) jumped 5.31% to $4.56 at 18:21 EST on Friday, after two consecutive sessions in a row of losses. NASDAQ Composite is jumping 0.05% to $14,942.83, following the last session’s downward trend. This seems, at the moment, a somewhat up trend exchanging session today.
Sorrento Therapeutics’s last close was $4.33, 74.9% below its 52-week high of $17.25.
Today’s last reported volume for Sorrento Therapeutics is 4544212 which is 16.26% below its average volume of 5426917.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is a negative 13.4% for the current quarter and 13% for the next. The company’s growth estimates for the present quarter and the next is 30.3% and 14.8%, respectively.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 84.6%, now sitting on 46.52M for the twelve trailing months.
Sorrento Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.31%, a negative 0.68%, and a positive 3.20%, respectively.
Sorrento Therapeutics’s highest amplitude of average volatility was 2.51% (last week), 3.08% (last month), and 3.20% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Sorrento Therapeutics’s stock is considered to be overbought (>=80).
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $4.56 at 18:21 EST, under its 52-week low of $4.69.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s value is way below its 50-day moving average of $6.36 and way under its 200-day moving average of $7.85.
More news about Sorrento Therapeutics (SRNE).